Mônica H. Cerqueira

Researcher
Instituto de Hematologia do Estado do Rio de Janeiro (Hemorio), Rio de Janeiro, Brazil

Presentation(s):

• PB0177 - Detection of IgG4 anti-FVIII levels as complementary test to define the ITI outcome in patients with hemophilia A: results from the BrazIT Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0178 - High plasma levels of IgG4 anti-FVIII is the hallmark of immune tolerance failure in patients with hereditary hemophilia A: results from the BrazIT Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0201 - Pathogenic variants in F8 gene - Results from the Brazilian Immune Tolerance (BrazIT) Study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0655 - Minor surgical procedures and the outcome of immunotolerance induction: an analysis of the BrazIT Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0678 - Changing Recombinant Factor VIII for Plasma-derived FVIII during Immune Tolerance Induction: Results from the Brazilian Immune Tolerance (BrazIT) Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0684 - Clinical Outcomes in Patients with Hemophilia A in Brazil: 3-years of Follow-up of the AHEAD International Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM